Renaissance closes first financing round:
This article was originally published in Clinica
Executive Summary
Renaissance Ventures, a newly-formed European biomedical seed capital fund, has closed its first financing round, raising around £10 million ($16 million) from a group of largely Swiss investors. The company, which is based in Jersey, aims to raise a further £20 million later this year from corporate and institutional investors.